Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top Correlated Resources
1518.HK
Top 10 Correlated ETFs
1518.HK
Top 10 Correlated Stocks
1518.HK
Financial details
Company Rating
Strong Buy
Market Cap
232.76M
Income
-
Revenue
-
Book val./share
0.27
Cash/share
0.39
Dividend
-
Dividend %
-
Employees
1.3K
Optionable
No
Shortable
Yes
Earnings
31 Aug 2022
P/E
2.5
Forward P/E
-
PEG
-
P/S
0.67
P/B
0.46
P/C
1.22
P/FCF
3.27
Quick Ratio
0.51
Current Ratio
0.99
Debt / Equity
-
LT Debt / Equity
0.43
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-72.84%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.35%
Revenue Q/Q
32.98%
EPS Q/Q
1571.76%
-
-
-
-
SMA20
-43.02%
SMA50
-47.31%
SMA100
-45.56%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
13%
ROC
0.13%
Gross Margin
51%
Oper. Margin
24%
Profit Margin
27%
Payout
-
Shs Outstand
490.02M
Shs Float
205.96M
-
-
-
-
Target Price
-
52W Range
0.42-1.21
52W High
-
52W Low
-
RSI
22.38
Rel Volume
-
Avg Volume
12.72K
Volume
Perf Week
-2.06%
Perf Month
-46.63%
Perf Quarter
-42.77%
Perf Half Y
-37.5%
-
-
-
-
Beta
0.735632
-
-
Volatility
0.02%, 0.17%
Prev Close
0%
Price
0.475
Change
-1.04%
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 1.14 | 1.28 | 1.5 | 1.06 | 1.3 | |
| Net income per share | 0.16 | 0.09 | -0.05 | -0.77 | -0.21 | |
| Operating cash flow per share | 0.21 | 0.04 | 0.26 | -0.01 | 0.05 | |
| Free cash flow per share | 0.19 | 0 | 0.21 | -0.04 | 0.02 | |
| Cash per share | 1.99 | 1 | 0.85 | 0.62 | 0.46 | |
| Book value per share | 2.62 | 2.63 | 2.54 | 1.67 | 1.52 | |
| Tangible book value per share | 2.1 | 1.24 | 1.12 | 0.8 | 1.41 | |
| Share holders equity per share | 2.62 | 2.63 | 2.54 | 1.67 | 1.52 | |
| Interest debt per share | 0 | 0 | 0.77 | 0.78 | 0.61 | |
| Market cap | 6.18B | 3.13B | 1.21B | 868.38M | 523.94M | |
| Enterprise value | 5.42B | 2.69B | 1.21B | 930.26M | 580.33M | |
| P/E ratio | 84.1 | 75.32 | -45.46 | -2.34 | -5.16 | |
| Price to sales ratio | 11.52 | 5.08 | 1.66 | 1.69 | 0.83 | |
| POCF ratio | 61.8 | 173.74 | 9.52 | -205.68 | 23.54 | |
| PFCF ratio | 67.37 | -3.14K | 11.59 | -46.36 | 57.58 | |
| P/B Ratio | 4.99 | 2.46 | 0.98 | 1.07 | 0.71 | |
| PTB ratio | 4.99 | 2.46 | 0.98 | 1.07 | 0.71 | |
| EV to sales | 10.1 | 4.37 | 1.67 | 1.81 | 0.92 | |
| Enterprise value over EBITDA | 39.59 | 21.42 | 8.46 | -4.39 | 20.78 | |
| EV to operating cash flow | 54.17 | 149.66 | 9.58 | -220.34 | 26.08 | |
| EV to free cash flow | 59.04 | -2.7K | 11.66 | -49.66 | 63.77 | |
| Earnings yield | 0.01 | 0.01 | -0.02 | -0.43 | -0.19 | |
| Free cash flow yield | 0.01 | 0 | 0.09 | -0.02 | 0.02 | |
| Debt to equity | 0 | 0 | 0.26 | 0.4 | 0.33 | |
| Debt to assets | 0.14 | 0.21 | 0.34 | 0.45 | 0.46 | |
| Net debt to EBITDA | -5.58 | -3.45 | 0.05 | -0.29 | 2.02 | |
| Current ratio | 6.47 | 2.1 | 2.14 | 1.88 | 1.58 | |
| Interest coverage | 5.87K | 0 | 3.59 | -2.68 | -2.69 | |
| Income quality | 1.36 | 0.43 | -4.77 | 0.01 | -0.22 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.37 | 0.34 | -0.12 | 0 | 0 | |
| Sales general and administrative to revenue | 0.15 | 0.19 | 0.2 | 0.24 | 0.25 | |
| Research and developement to revenue | 0 | 0 | 0.01 | 0.03 | 0.02 | |
| Intangibles to total assets | 0.17 | 0.42 | 0.37 | 0.29 | 0 | |
| Capex to operating cash flow | -0.08 | -1.06 | -0.18 | 3.44 | -0.59 | |
| Capex to revenue | -0.02 | -0.03 | -0.03 | -0.03 | -0.02 | |
| Capex to depreciation | -0.45 | -0.49 | -0.21 | -0.15 | -0.15 | |
| Stock based compensation to revenue | 0.03 | 0.02 | 0.01 | 0 | 0 | |
| Graham number | 3.03 | 2.26 | 1.77 | 5.37 | 2.67 | |
| ROIC | 0.12 | 0.07 | 0.04 | -0.04 | -0.05 | |
| Return on tangible assets | 0.06 | 0.04 | -0.02 | -0.35 | -0.08 | |
| Graham Net | 1.56 | 0.31 | -0.46 | -0.72 | -0.73 | |
| Working capital | 911.92M | 343.26M | 334.69M | 245.74M | 170.25M | |
| Tangible asset value | 993.88M | 600.54M | 540.63M | 387.52M | 0 | |
| Net current asset value | 875.14M | 316.04M | -13.99M | -133.94M | -125.23M | |
| Invested capital | 0 | 0 | 0.29 | 0.44 | 0.38 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 21.44M | 24.67M | 25.99M | 25.62M | 26.53M | |
| Average inventory | 13.39M | 16.65M | 17.64M | 19.58M | 20.36M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 22.66 | 22.89 | 20.55 | 24.8 | 23.09 | |
| Days of inventory on hand | 9.44 | 13.23 | 12.23 | 18.96 | 17.79 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 16.11 | 15.95 | 17.76 | 14.72 | 15.81 | |
| Inventory turnover | 38.67 | 27.59 | 29.84 | 19.25 | 20.52 | |
| ROE | 0.06 | 0.03 | -0.02 | -0.46 | -0.14 | |
| Capex per share | -0.02 | -0.04 | -0.05 | -0.03 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2016-12-31 for Q4
| Metric | History | 2016-12-31 |
|---|---|---|
| Revenue per share | 0.31 | |
| Net income per share | 0.16 | |
| Operating cash flow per share | 0.09 | |
| Free cash flow per share | 0.08 | |
| Cash per share | 0.39 | |
| Book value per share | 0.27 | |
| Tangible book value per share | -0.24 | |
| Share holders equity per share | 0.27 | |
| Interest debt per share | 0.04 | |
| Market cap | 3.6B | |
| Enterprise value | 3.43B | |
| P/E ratio | 11.33 | |
| Price to sales ratio | 23.87 | |
| POCF ratio | 83.79 | |
| PFCF ratio | 86.82 | |
| P/B Ratio | 26.77 | |
| PTB ratio | 26.77 | |
| EV to sales | 22.75 | |
| Enterprise value over EBITDA | 34.93 | |
| EV to operating cash flow | 79.86 | |
| EV to free cash flow | 82.75 | |
| Earnings yield | 0.02 | |
| Free cash flow yield | 0.01 | |
| Debt to equity | 0 | |
| Debt to assets | 0.79 | |
| Net debt to EBITDA | -1.72 | |
| Current ratio | 1.17 | |
| Interest coverage | 111.43 | |
| Income quality | 0.54 | |
| Dividend Yield | 0 | |
| Payout ratio | 0 | |
| Sales general and administrative to revenue | 0.25 | |
| Research and developement to revenue | 0 | |
| Intangibles to total assets | 0.39 | |
| Capex to operating cash flow | -0.03 | |
| Capex to revenue | -0.01 | |
| Capex to depreciation | -0.29 | |
| Stock based compensation to revenue | 0 | |
| Graham number | 1 | |
| ROIC | 0.09 | |
| Return on tangible assets | 0.21 | |
| Graham Net | -0.63 | |
| Working capital | 37.2M | |
| Tangible asset value | -115.46M | |
| Net current asset value | -250.82M | |
| Invested capital | 0.15 | |
| Average receivables | 0 | |
| Average payables | 22.15M | |
| Average inventory | 13.8M | |
| Days sales outstanding | 0 | |
| Days payables outstanding | 21.2 | |
| Days of inventory on hand | 8.12 | |
| Receivables turnover | 0 | |
| Payables turnover | 4.25 | |
| Inventory turnover | 11.09 | |
| ROE | 0.59 | |
| Capex per share | 0 |
Frequently Asked Questions
What is New Century Healthcare Holding Co. Limited stock symbol ?
New Century Healthcare Holding Co. Limited is a CN stock , located in Beijing of Beijing and trading under the symbol 1518.HK
What is New Century Healthcare Holding Co. Limited stock quote today ?
New Century Healthcare Holding Co. Limited stock price is $0.475 today.
Is New Century Healthcare Holding Co. Limited stock public?
Yes, New Century Healthcare Holding Co. Limited is a publicly traded company.
Company Profile
- Volume Average 12.72K
- Market Capitalization 232.76M
- Employee 1.3K
- CEO Mr. Jason Zhou
- Headquarters Beijing,BEIJING,CN
- IPO Date 2017-01-18
-
Website
https://www.ncich.com.cn 
New Century Healthcare Holding Co. Limited, an investment holding company, provides healthcare services to women and children in the People's Republic of China. The company offers paediatric, obstetric, and gynaecologic specialty services, as well as hospital consulting services. It also provides online healthcare services, as well as operates cafeteria and gift shop at its medical institutions. The company was founded in 2002 and is headquartered in Beijing, the People's Republic of China.
